Physician profile
Steven Parry
NPI 1508210725
$26,187.18
in general payments reported to CMS, 2019-2025
9 companies · $1,665 in 2025
The $1,665 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19K · 2022: $2,525 · 2023: $3,115 · 2024: $282 · 2025: $1,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,441 · Food and Beverage: $1,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,440.81 |
| Food and Beverage | $1,621.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,000.00 | 2021 | |
| Alon Medical Technology | $6,000.00 | 2021-2022 | |
| Stryker Corporation | $3,996.38 | 2023-2025 | Salvation, Mako, Inspace |
| Zimmer Biomet Holdings, INC. | $869.16 | 2025 | Avenir |
| Pacira Pharmaceuticals Incorporated | $124.69 | 2022 | |
| Linvatec Corporation | $105.36 | 2024 | Biobrace 23mm, Allograft Tissue |
| Polaris Technology Solutions LLC | $55.39 | 2024-2025 | |
| Medical Device Business Services, INC. | $22.34 | 2024 | Reclaim |
| Fidia Pharma USA INC. | $13.86 | 2024 | Hym/Hyn |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Parry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.